Fortress Biotech, Inc. Research And Development Expense

• Fortress Biotech, Inc. showed an increase of +72.5% in Research And Development Expense from 2017 to 2018.
• This data is from Fortress Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2019.
• XBRL data for this metric is available from 2009 to 2018 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2010: $1.82 million | Q1 2011: $1.25 million | Q2 2011: $2.14 million | Q3 2011: $1.75 million | Q1 2012: $4.58 million | Q2 2012: $4.53 million | Q3 2012: $3.78 million | Q1 2013: $5.97 million | Q2 2013: $7.80 million | Q3 2013: $5.36 million | Q1 2014: $4.49 million | Q2 2014: $2.38 million | Q3 2014: $1.61 million | Q1 2015: $1.64 million | Q2 2015: $2.41 million | Q3 2015: $9.07 million | Q1 2016: $7.74 million | Q2 2016: $6.35 million | Q3 2016: $7.32 million | Q1 2017: $8.40 million | Q1 2018: $24.96 million | Q1 2019: $23.27 million.
• Over the full 10 years of available data (2009 to 2018), Fortress Biotech, Inc.'s Research And Development Expense has grown by 3,571.1%.
• Historical annual values: Fiscal year 2018: $83.33 million | Fiscal year 2017: $48.32 million | Fiscal year 2016: $35.13 million | Fiscal year 2015: $29.81 million | Fiscal year 2014: $10.24 million | Fiscal year 2013: $25.68 million | Fiscal year 2012: $17.47 million | Fiscal year 2011: $8.58 million | Fiscal year 2010: $8.34 million | Fiscal year 2009: $2.27 million.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026